Insider Trading activities of Leap Therapeutics, Inc. (LPTX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Leap Therapeutics, Inc. (LPTX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Leap Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Leap Therapeutics, Inc. since 2005. The reporting company's ticker symbol is LPTX. The reporting company's CIK number is 1509745.
The total value of stock buying since 2005 is $29,746,092.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Leap Therapeutics, Inc. (LPTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-02 2,285,712 $3,999,996 0 $0 0 $0
2017-11 4,231,076 $25,746,096 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Leap Therapeutics, Inc. insiders (LPTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-02-05 Healthcare Partners Ix, Llc (10% Owner) Buy 571,428 1.75 999,999
2019-02-05 Onsi Douglas E (CFO, GC, Treasurer & Secretary) Buy 571,428 1.75 999,999
2019-02-05 Lawlor Augustine (Chief Operating Officer) Buy 571,428 1.75 999,999
2019-02-05 Mirabelli Christopher (CEO, President, Chairman) Buy 571,428 1.75 999,999
2017-11-14 Healthcare Partners Ix, Llc (10% Owner) Buy 1,057,769 6.08 6,436,524
2017-11-14 Onsi Douglas E (CFO, GC, Treasurer & Secretary) Buy 1,057,769 6.08 6,436,524
2017-11-14 Lawlor Augustine (Chief Operating Officer) Buy 1,057,769 6.08 6,436,524
2017-11-14 Mirabelli Christopher (CEO, President, COB) Buy 1,057,769 6.08 6,436,524

Insider trading activities including stock purchases, stock sales, and option exercises of LPTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Leap Therapeutics, Inc. (symbol LPTX, CIK number 1509745) see the Securities and Exchange Commission (SEC) website.